PTEN and neoplasm: Low to moderate levels of ROS induce activation of the PI3K/Akt pathway and promote tumor signaling by interfering with PTEN, protein tyrosine phosphatase 1B, and protein phosphatase 2 (Koundouros and Poulogiannis, 2018).